Odi Bruckman (@odibro) 's Twitter Profile
Odi Bruckman

@odibro

Biotech Stocks News

ID: 126416038

calendar_today25-03-2010 20:17:38

30,30K Tweet

12,12K Followers

180 Following

Odi Bruckman (@odibro) 's Twitter Profile Photo

$AZN $MRK Lynparza demonstrated overall survival benefit in Phase III PROfound trial for BRCA1/2 or ATM-mutated metastatic castration-resistant prostate cancer astrazeneca.com/media-centre/p…

David Grainger (@sciencescanner) 's Twitter Profile Photo

The biggest lesson from #COVID19 is that our belief in the ability of modern technology, modern logistics and modern society to keep us safe are over-stated Nature, red in tooth and claw, is still the boss and we humans a mere bagatelle

Bloomberg Opinion (@opinion) 's Twitter Profile Photo

A mass testing in the Italian town of Vo’ Euganeo, in the northeast of Italy, found more than 40% of those infected had no symptoms trib.al/p4IL43w

Bloomberg (@business) 's Twitter Profile Photo

The WHO and the leaders of France and Germany launch an $8 billion drive to accelerate development of a coronavirus vaccine trib.al/WdMMDQQ

SY Investing (@syinvesting) 's Twitter Profile Photo

#COVID19 $GILD Japan's Prime Minister, Shinzō Abe, says coronavirus drug candidate remdesivir may soon be granted special approval. reuters.com/article/brief-…

Genentech (@genentech) 's Twitter Profile Photo

#Breaking: Pivotal data evaluating spinal muscular atrophy (SMA) medicine shows study met its primary endpoint in infants with Type 1 #SMA. gene.com/media/press-re…

Moderna (@moderna_tx) 's Twitter Profile Photo

Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: buff.ly/2Yn8LtG #mRNA

Moderna and @LonzaPB announce worldwide strategic collaboration to manufacture Moderna's #vaccine (mRNA-1273) against novel coronavirus. Read more: buff.ly/2Yn8LtG #mRNA
Michelle Solly (@msollender) 's Twitter Profile Photo

$ADVM +22% OPTIC data $AKBA +21% INNO2VATE data $BNTX +6% Initiating mRNA vaccine trial in humans $KPTI -7% On earnings $PTLA +131% Buyout ($18/sh) $TGTX +40% UNITY-CLL met primary

M (@bio_clouseau) 's Twitter Profile Photo

$NVO Semaglutide in NASH P2 +ve for all 3 doses. Resolution of NASH + no worsening in fibrosis 59% for high dose vs 17% for placebo @ 72 wks. Comparatively $NGM FGF19 @ WK 24 24% vs 9% $ICPT $MDGL $VKTX $AKRO

$NVO Semaglutide in NASH P2 +ve for all 3 doses. Resolution of NASH + no worsening in fibrosis 59% for high dose vs 17% for placebo @ 72 wks. Comparatively $NGM FGF19 @ WK 24 24% vs 9% $ICPT $MDGL $VKTX $AKRO
Tom Silver (@tomsilver39) 's Twitter Profile Photo

Jefferies:" Polled US Health Care analysts favorite names. 10 Buy rated stocks for investors to chew on: $AMGN; $DXCM; $FGEN; $GILD; $HAE; $IOVA; $REGN; $VRTX; $ZBH; $ZNTL."